# Relmada Therapeutics, Inc.: Form 8-K, filed May 15, 2023

- Company: [Relmada Therapeutics, Inc.](/companies/rlmd.md) (CIK 1553643)
- Form: 8-K
- Filed: 2023-05-15
- Accepted by EDGAR: May 15, 2023, 17:29 ET
- Period: 2023-05-15
- Accession: 0001213900-23-040004
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1553643/000121390023040004/ea178627-8k_relmada.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553643/000121390023040004/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1553643/000121390023040004/ea178627-8k_relmada.htm

Filed May 15, 2023.
Source: SEC EDGAR, the filing index for accession 0001213900-23-040004. Last ingested by Listed: Nov 13, 2026, 15:42 ET. No prices; not investment advice.
